Drugs Made In America Acquisition (DMAA) Current Assets (2024 - 2025)
Drugs Made In America Acquisition (DMAA) reported Current Assets of $12191.0 for Q4 2025, up 144.26% on a YoY basis from $4991.0 in Q4 2024, and down 56.76% quarter-over-quarter from $28196.0 in Q3 2025.
Drugs Made In America Acquisition (DMAA) Current Assets (2024 - 2025) Analysis & Trends
Drugs Made In America Acquisition has reported Current Assets for 2 years, with the latest figure at $12191.0 in Q4 2025.
- For the quarter ending Q4 2025, Current Assets rose 144.26% year-over-year to $12191.0; the trailing twelve-month figure through Dec 2025 stood at $12191.0 (up 144.26% YoY), and the FY2025 full-year result was $12191.0, up 144.26% from the prior year.
- Current Assets for Q4 2025 stood at $12191.0, down from $28196.0 in the prior quarter.
- The five-year high for Current Assets was $71019.0 in Q1 2025, with the low at $4991.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | 1.58 Mn |
| 2 | Berto Acquisition | 312.46 Mn | 312.46 Mn | - | 405,162.00 |
| 3 | Centurion Acquisition | 311.65 Mn | 311.65 Mn | - | 54,530.00 |
| 4 | GP-Act III Acquisition | 311.36 Mn | 311.36 Mn | - | 188,111.00 |
| 5 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - | 280,749.00 |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - | 681,487.00 |
| 7 | Bold Eagle Acquisition | 275.54 Mn | 275.54 Mn | - | 665,298.00 |
| 8 | Soulpower Acquisition | 264.91 Mn | 264.91 Mn | - | 2.53 Mn |
| 9 | BTC Development | 262.16 Mn | 262.16 Mn | - | 1.72 Mn |
| 10 | Drugs Made In America Acquisition | 223.11 Mn | 223.11 Mn | - | 12,191.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12,191.00 |
| Sep 30, 2025 | 28,196.00 |
| Jun 30, 2025 | 49,726.00 |
| Mar 31, 2025 | 71,019.00 |
| Dec 31, 2024 | 4,991.00 |